Congress Trades in BioMarin Pharmaceutical Inc. (BMRN)

7 members of Congress have disclosed trading BMRN.

Total trades
14
Purchases
7
Sales
7
Members
7
Est. volume
$97,409
Last traded
Mar 6, 2023

7 members of Congress have disclosed trading BioMarin Pharmaceutical Inc. (BMRN), with 14 transactions in total — 7 purchases and 7 sales worth an estimated $97,409 at range midpoints, leaning evenly between buying and selling. The most active BMRN trader is Alan S. Lowenthal (6 disclosures). The most recent disclosed BMRN trade was on Mar 6, 2023.

Every disclosed BMRN trade

DisclosedPoliticianTypeAmountTraded
Apr 3, 2023 Daniel Goldman Sale $1,001 - $15,000 Mar 6, 2023 filing ↗
Nov 4, 2020 Josh Gottheimer D Purchase $1,001 - $15,000 Oct 16, 2020 filing ↗
Jan 6, 2020 Josh Gottheimer D Purchase $1,001 - $15,000 Dec 11, 2019 filing ↗
Aug 29, 2019 Alan S. Lowenthal Sale $506.27 Aug 15, 2019 filing ↗
Aug 29, 2019 Alan S. Lowenthal Sale $1,001 - $15,000 Aug 15, 2019 filing ↗
Mar 25, 2019 Nicholas Van Taylor Sale $1,001 - $15,000 Mar 25, 2019 filing ↗
Jun 4, 2018 Alan S. Lowenthal Purchase $903.36 May 29, 2018 filing ↗
May 3, 2018 Alan S. Lowenthal Purchase $1,001 - $15,000 Apr 27, 2018 filing ↗
May 2, 2018 Alan S. Lowenthal Purchase $1,001 - $15,000 Apr 26, 2018 filing ↗
Mar 5, 2018 Lamar Smith Sale $1,001 - $15,000 Feb 12, 2018 filing ↗
Jan 21, 2018 Alan S. Lowenthal Purchase $1,001 - $15,000 Jan 17, 2018 filing ↗
Sep 15, 2016 K. Michael Conaway Sale $1,001 - $15,000 Sep 12, 2016 filing ↗
Feb 1, 2015 Thomas MacArthur Sale $1,001 - $15,000 Jan 27, 2015 filing ↗
Dec 1, 2014 Lamar Smith Purchase $1,001 - $15,000 Nov 14, 2014 filing ↗

Most active BMRN traders in Congress

AS Alan S. Lowenthal 6 trades Josh Gottheimer Josh Gottheimer Democrat 2 trades LS Lamar Smith 2 trades DG Daniel Goldman 1 trade NV Nicholas Van Taylor 1 trade KM K. Michael Conaway 1 trade TM Thomas MacArthur 1 trade

Source: US House Clerk Periodic Transaction Reports. Amounts are disclosed as ranges; estimates use range midpoints. Data may be delayed or contain filer errors. Not investment advice.